← All OCC Flashcard Decks

OCC Evidence-Based Medicine & Research Flashcards

6 cards from real OCC practice questions. Tap to flip, then mark Knew It or Still Learning — missed cards come back until you master them.

Read the first 6 OCC Evidence-Based Medicine & Research flashcards as text
  1. Which organization produces the US Preventive Services Task Force (USPSTF) recommendations that inform ACA-covered preventive services?

    Answer: Agency for Healthcare Research and Quality (AHRQ)

    The USPSTF is an independent panel convened and supported by the AHRQ that produces evidence-based preventive service recommendations.

  2. In clinical research, which type of validity refers to whether study findings can be generalized to the broader population?

    Answer: External validity

    External validity (generalizability) refers to whether the study findings apply beyond the specific study sample to the target population.

  3. A systematic review finds significant heterogeneity among included studies (I² = 78%). What does this indicate?

    Answer: High variability across studies suggests caution in pooling results

    I² > 75% indicates substantial heterogeneity, meaning considerable variability exists between study results that cannot be attributed to chance alone.

  4. Which type of error occurs when a study fails to detect a real treatment effect due to inadequate sample size?

    Answer: Type II error (beta error)

    A Type II (beta) error is a false negative — failing to detect a real difference because the study lacked sufficient statistical power (adequate sample size).

  5. Pre-registration of clinical trial protocols in databases like ClinicalTrials.gov is intended to prevent which bias?

    Answer: Publication bias and selective outcome reporting

    Pre-registration prevents selective outcome reporting and publication bias by making the original hypotheses public before data collection begins.

  6. Osteopathic manipulative medicine (OMM) research faces which unique methodological challenge not present in pharmaceutical trials?

    Answer: Blinding participants and practitioners to the treatment intervention is extremely difficult

    Unlike drug trials where placebo pills are feasible, truly blinding OMM trials is very difficult because practitioners and often patients know whether manipulation was performed.

How this page was made: written with AI tools and published by Nathan Beja, founder of Practice Test Geeks, who is responsible for its content. Exam facts are checked against the official sources listed below. Not reviewed by a subject-matter expert. Editorial policy

Sources & references

Exam facts on this page (fees, format, dates, passing scores) are checked against these official sources; the date is our last check. Editorial policy

  1. certification.osteopathic.org — Test delivery, registration deadline, renewal, score validity, fees, exam format, passing score, registration, retake policy, test dates · verified Oct 2026